BioCentury
ARTICLE | Clinical News

SangStat regulatory update

October 2, 1995 7:00 AM UTC

SANG (Menlo Park, Calif.) submitted a 510(k) with the FDA for marketing approval of its Celsior solution to preserve the heart prior to cardiac transplantation and to promote graft function in the initial 48 hours after cardiac transplant surgery. ...